India In-vitro Fertilization Market to Grow with a CAGR of 8.92% through 2029
Growing success rate of IVF technology and increasing
cases of infertility is expected to drive the India In-vitro Fertilization
Market growth in the forecast period, 2025-2029.
According to
TechSci Research report, “India In-vitro Fertilization Market -Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2029”,
the India In-vitro Fertilization Market stood at USD 845.07 Million in 2023 and is anticipated to grow
with a CAGR of 8.92% in the forecast period, 2025-2029. Several factors are
driving the growth of the in-vitro fertilization (IVF) market in India. The
increasing incidence of infertility due to lifestyle changes, such as delayed
childbearing and increasing stress levels, are contributing to the growth.
Advancements in IVF technology, such as the introduction of time-lapse imaging
and preimplantation genetic diagnosis, are also propelling the market.
Furthermore,
government initiatives to promote medical tourism, combined with the
cost-effectiveness of IVF procedures in India compared to other countries, are
attracting patients from all over the world. The rise in disposable income and
increased awareness about IVF among the general population are also significant
factors.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "India In-vitro Fertilization Market”
The Indian
In-vitro Fertilization (IVF) market has witnessed an unprecedented growth in
recent years, driven by the rising prevalence of infertility, advancements in
technology, and growing awareness and acceptance of IVF treatments.
Infertility, defined as the inability to conceive after a year of trying,
affects approximately 10-14% of the Indian population, propelling the demand
for effective treatments like IVF.
Technological
advancements in the field, like the introduction of time-lapse imaging and
preimplantation genetic testing, have significantly improved the success rates
of IVF treatments and made it an increasingly popular choice for childless
couples. Time-lapse imaging allows for continuous monitoring of the developing
embryos without the need for removal from the incubator, reducing external disturbances
and improving the chances of successful implantation. Preimplantation genetic
testing enables the identification of genetic defects within embryos, ensuring
that only healthy embryos are implanted, thus reducing the risk of genetic
disorders and increasing the overall success rate of IVF cycles.
The importance
of these advancements cannot be overstated, particularly in a society where the
pressure to have a child can be overwhelming. Indian society places a high
value on parenthood, and the inability to have children can lead to social
stigma, making the promise of successful IVF treatments even more appealing.
Moreover,
increased awareness and acceptance of IVF treatments have also played a
significant role in the growth of the market. Various awareness campaigns have
been launched to educate the public about infertility and the available
treatment options. Additionally, celebrity endorsements and testimonials have
helped destigmatize IVF, making it an increasingly accepted treatment method. However,
despite the positive growth in the market, the high cost of IVF procedures and
the lack of insurance coverage continue to be deterrents for many couples. Looking
ahead, the Indian IVF market shows great promise. Ongoing advancements in
technology will continue to enhance treatment outcomes, while growing awareness
and acceptance will further expand the market. However, the challenge remains
in making these treatments more accessible and affordable to the masses in
order to truly unlock the potential of this market.
The India In-vitro
Fertilization Market is segmented into technique, product, donor, infertility,
embryo, end user, regional distribution, and company.
Based on technique,
the Intracytoplasmic Sperm Injection (ICSI) IVF technique is projected to
dominate the IVF market in India, owing to its higher success rate compared to
Non-ICSI/Traditional IVF. This is particularly beneficial in cases of severe
male infertility, where the precise and targeted approach of ICSI significantly
enhances the chances of successful fertilization.
Moreover, the
growing awareness about the benefits of ICSI IVF among patients and healthcare
providers alike has led to an increased demand for this advanced technique. The
remarkable success stories of couples who have achieved parenthood through ICSI
IVF have further fueled the interest in this cutting-edge reproductive
technology. With the increasing availability of ICSI IVF in modern healthcare
facilities across India, more couples struggling with infertility are now able
to access and benefit from this revolutionary treatment. Given these factors,
it is anticipated that the dominance of ICSI IVF in the Indian market will
continue to expand. As more individuals and healthcare professionals recognize
the potential advantages it offers in the treatment of infertility, the
prevalence of ICSI IVF is poised to grow, bringing hope and joy to countless
families across the nation.
Based on region,
the West India region is predominantly leading the Indian in-vitro fertilization
(IVF) market due to a multitude of factors. Firstly, states in this region,
especially Maharashtra and Gujarat, have a higher number of fertility clinics
and hospitals, offering advanced and quality fertility treatments. These
clinics and hospitals are equipped with state-of-the-art facilities and staffed
by skilled medical professionals who specialize in reproductive medicine. The
affluent economic status of the populace in this region allows for a higher
spending capacity on treatments like IVF. This enables individuals and couples
to access the latest advancements in assisted reproductive technology, such as
preimplantation genetic testing and intracytoplasmic sperm injection, which can
increase the chances of successful pregnancies.
Moreover, there
is greater awareness and acceptance of IVF treatments in these areas, boosted
by progressive societal norms and increased literacy rates. Educational
campaigns and support groups have played a significant role in disseminating
information about the benefits and success rates of IVF, thereby reducing the
stigma associated with fertility treatments. Furthermore, the West India region
benefits from a robust network of ancillary services related to IVF, including
embryology laboratories, cryopreservation facilities, and fertility counseling
centers. These additional services enhance the overall experience for patients,
ensuring comprehensive care throughout their fertility journey. The presence of
leading academic institutions and research centers in this region fosters
innovation and collaboration among scientists, clinicians, and embryologists.
This creates a conducive environment for groundbreaking research and the
development of cutting-edge techniques in assisted reproductive technology. All
these factors combined contribute to the dominance of the West India region in
the Indian IVF market, making it a preferred destination for individuals
seeking fertility treatments.
Major companies
operating in India In-vitro Fertilization Market are:
- Merck
India
- ORIGIO India Pvt Ltd.
- IMV India Pvt. Ltd.
- Thermo Fisher Scientific India Pvt. Ltd.
- Travancore Trade Links
- Cook Medical India
- Morpheus Life Sciences Pvt. Ltd.
- Max Healthcare Institute Limited
- Olympus Medical Systems India Pvt Ltd.
- FUJIFILM India Pvt Ltd.
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The future of
the In-vitro Fertilization (IVF) market in India appears promising, driven by
an increasing prevalence of infertility, advancements in technology, and a
growing acceptance of IVF procedures. Trends suggest a progressive rise in the
use of assisted reproductive technology due to a change in socio-cultural
attitudes. However, factors such as expensive treatment procedures and lack of
stringent regulatory framework may pose challenges to the growth of the market.
Nonetheless, the rising middle-class population and their increasing disposable
income are expected to provide ample opportunities for the expansion of the IVF
market in India.,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based management consulting firm.
“India In-vitro
Fertilization Market By Technique (ICSI IVF, Non-ICSI/ Traditional IVF), By Product
(IVF Culture Media, ICSI Machine, IVF Incubators, Cryosystem, Others), By Donor
(Fresh Non-donor, Frozen Non-donor, Fresh Donor, Frozen Donor), By Infertility
(Male, Female), By Embryo (Fresh Embryo, Frozen-thawed Embryo), By End User
(Fertility Clinics, Hospitals, Others), By Region, Competition, Forecast &
Opportunities, 2019-2019F”,
has evaluated the future growth potential of India In-vitro Fertilization
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in India In-vitro
Fertilization Market.
Contact
Techsci Research
LLC
420 Lexington
Avenue, Suite 300,
New York, United
States- 10170
M: +13322586602
Email: [email protected]
Web: www.techsciresearch.com